Actively Recruiting
Study of Gamma Delta T Cell Recovery and Its Impact After Unrelated Umbilical Cord Blood Transplant for Blood Disorders
Led by Anhui Provincial Hospital · Updated on 2026-08-24
100
Participants Needed
1
Research Sites
204 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the recovery patterns of gamma delta T cells after allogeneic umbilical cord blood transplantation UCBT, a treatment for blood cancers and other disorders. The study aims to understand how the reconstitution of these immune cells relates to important outcomes like graft-versus-host disease GVHD, relapse rates, transplant-related mortality, and overall survival. This observational study seeks to uncover new markers that could guide future immune therapies to improve patient prognosis. Participants in this study have undergone unrelated cord blood transplants. Researchers will collect blood samples over time to monitor the amount, proportion, and changes in major functional subsets of T cells using flow cytometry. The study focuses on describing the immune recovery process without administering new treatments, following all patients in a single cohort. Throughout the study, participants will have their immune cells and clinical outcomes closely observed and recorded. Key outcomes include the level of T cell recovery at one year, survival rates up to five years, relapse incidence, and occurrence of acute and chronic GVHD. This long-term monitoring will help link immune cell patterns to health outcomes after transplantation, with the study expected to continue until 2030.
CONDITIONS
Brief Title
Reconstruction Kinetics of γδ T Cells After Unrelated Cord Blood Transplantation
Research Team
X
Xiao yu Zhu, ph.D
X
Xing chi Chen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here